Tumour cell resistance to non-MHC-restricted lymphocytes molecular mechanisms and clinical implications
Target ArticleEdit
Tumour cell resistance to non-MHC-restricted lymphocytes molecular mechanisms and clinical implications; P Tagliaferri, Guarrasi, M Caraglia, D Morelliae; 1998; doi_citing_unknown
RetractionEdit
Oligosaccharide Ligands for NKR-P1 Protein Activate NK Cells and Cytotoxicity ; Karel Bezouska Chun-ting Yuen Jacqui O'Brien Robert A Childs Wengang Chai Karel Drbal Anna Fis; 11/10/1994
Citation pieceEdit
Note: Open to append information.